Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

Title: Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
Authors: Capparelli, EV; Aweeka, F; Hitti, J; Stek, A; Hu, C; Burchett, SK; Best, B; Smith, E; Read, JS; Watts, H; Nachman, S; Thorpe, EM; Spector, SA; Jimenez, E; Shearer, WT; Foca, M; Mirochnick, M
Source: HIV Medicine ; volume 9, issue 4, page 214-220 ; ISSN 1464-2662 1468-1293
Publisher Information: Wiley
Publication Year: 2008
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Objectives To determine the impact of pregnancy on the pharmacokinetics (PK) of nevirapine (NVP) during chronic dosing in HIV‐infected women and appropriate NVP dosing in this population. Methods Twenty‐six pregnant women participating in two open‐label Pediatric AIDS Clinical Trials Group studies (P1022 and P1026S) were evaluated. Each patient received 200 mg NVP every 12 h and had PK evaluations during the second or third trimester; these evaluations were repeated postpartum. Paired maternal and cord blood NVP concentrations were collected at delivery in nine patients. Ante‐ and postpartum comparisons were made using paired t ‐tests and using a ‘bioequivalence’ approach to determine confidence interval (CI). Results The average NVP Area Under the Curve (AUC) was 56 ± 13 mcg * h/mL antepartum and 61 ± 15 mcg * h/mL postpartum. The typical parameters ± standard error were apparent clearance (CL/F)=3.51 ± 0.18 L/h and apparent volume of distribution (Vd/F)=121 ± 19.8 L. There were no significant differences between antepartum and postpartum AUC or pre‐dose concentrations. The AUC ratio was 0.90 with a 90% CI of the mean equal to 0.80–1.02. The median (± standard deviation) cord blood to maternal NVP concentration ratio was 0.91 ± 0.90. Conclusions Pregnancy does not alter NVP PK and the standard dose (200 mg every 12 h) is appropriate during pregnancy.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1111/j.1468-1293.2008.00553.x
Availability: https://doi.org/10.1111/j.1468-1293.2008.00553.x; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1468-1293.2008.00553.x; https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1468-1293.2008.00553.x
Rights: http://onlinelibrary.wiley.com/termsAndConditions#vor
Accession Number: edsbas.259F5A65
Database: BASE